This photo provided Oct. 9, 2012, by the Minnesota Department of Health shows shows vials of the injectable steroid product made by New England Compounding Center implicated in a fungal meningitis outbreak that were being shipped to the Centers for Disease Control and Prevention in Atlanta from Minneapolis. About 17,700 single-dose vials of the steroid sent to 23 states have been recalled. The outbreak involves 10 states, including Minnesota.
Minnesota has recorded its 12th case in a national outbreak of fungal infections linked to tainted steroids from a Massachusetts pharmacy.
The new patient is a man in his 50s, the state Department of Health said Tuesday. The agency said the patient has survived, but released no other information about the case.
So far, 11 Minnesota patients have contracted fungal meningitis linked to the tainted injections, and one developed a related fungal bone/joint disease. None of the Minnesota patients has died.
Nationally, 438 people have tested positive for fungal meningitis, the Centers for Disease Control and Prevention said in its latest update. Another 10 have developed a related fungal joint infection, and 32 patients have died.
Also Tuesday, attorneys said a woman from Ham Lake has filed suit against the source pharmacy, the New England Compounding Center, bringing the number of Minnesota plaintiffs to at least four.